Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase.-Reference-Cited by-同舟云学术

Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase.

Published:1987-01 Issue:3 Volume:27 Page:295-306
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Halpern Z,Dudley M A,Lynn M P,Nader J M,Breuer A C,Holzbach R T

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference41 articles.

1. A non-micellar mode of cholesterol transport in human bile;Sömjen;FEBS Lett.,1983

2. Quasi-elastic lightscattering studies of aqueous biliary lipid systems. Cholesterol solubilization and precipitation in model bile solutions;Mazer;Biochemistry.,1983

3. Cholesterol nucleation in human bile by video-enhanced contrastdifferential interference microscopy (VEM): the role of vesicles in metastable supersaturation;Kibe;Gastroenterology.,1984

4. Solubilization of cholesterol in human bile;Pattinson;FEBS Lett.,1985

5. Rapid vesicle formation and aggregation in abnormal human biles: a time-lapse video-enhanced contrast microscopy study;Halpern;Gastroenterology.,1986

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation;Advances in Therapy;2023-01-05

2. Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis;Genes;2022-06-11

3. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13;Genes;2020-11-29

4. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades;Journal of Lipid Research;2014-08

5. Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease;Expert Opinion on Pharmacotherapy;2012-05-21